The master regulator of MHC-II gene transcription, class II transactivator (CIITA), acts as a potent inhibitor of human T cell leukemia virus type 2 (HTLV-2) replication by blocking the activity of the viral Tax-2 transactivator. Here, we show that this inhibitory effect takes place at the nuclear level and maps to the N-terminal 1-321 region of CIITA, where we identified a minimal domain, from positions 64 -144, that is strictly required to suppress Tax-2 function. Furthermore, we show that Tax-2 specifically cooperates with cAMP response element binding protein-binding protein (CBP) and p300, but not with p300͞CBP-associated factor, to enhance transcription from the viral promoter. This finding represents a unique difference with respect to Tax-1, which uses all three coactivators to transactivate the human T cell leukemia virus type 1 LTR. Direct sequestering of CBP or p300 is not the primary mechanism by which CIITA causes suppression of Tax-2. Interestingly, we found that the transcription factor nuclear factor Y, which interacts with CIITA to increase transcription of MHC-II genes, exerts a negative regulatory action on the Tax-2-mediated HTLV-2 LTR transactivation. Thus, CIITA may inhibit Tax-2 function, at least in part, through nuclear factor Y. These findings demonstrate the dual defensive role of CIITA against pathogens: it increases the antigen-presenting function for viral determinants and suppresses HTLV-2 replication in infected cells. Tax-2 
H
uman T cell leukemia virus type 1 (HTLV-1) and human T cell leukemia virus type 2 (HTLV-2) are related retroviruses with similar genomic organization and common modes of transmission but different disease manifestations (1) (2) (3) .
HTLV-1 is the etiologic agent of adult T cell leukemia͞ lymphoma and tropical spastic paraparesis͞HTLV-1-associated myelopathy (4) (5) (6) (7) .
Although originally isolated from a case of atypical hairy T cell leukemia (8) , HTLV-2 has not been epidemiologically linked to lymphoproliferative disorders (9) . Few reports have described an association with tropical spastic paraparesis͞HTLV-1-associated myelopathy-''like'' cases (10, 11) .
HTLV-1 and HTLV-2 show a preferential tropism for CD4 ϩ and CD8 ϩ T cells, respectively, but they can also infect other populations, including monocytes and B cells (12) (13) (14) (15) (16) . Both viruses encode homologous transcription activators, respectively designated as Tax-1 and Tax-2, that are important mediators of viral pathogenesis and essential for immortalization of T lymphocytes (17, 18) .
Tax-1 activates transcription of the HTLV-1 viral genome by interacting with the cAMP response element binding proteinbinding protein (CBP)͞ATF family of transcription factors, which bind to the viral LTR (19, 20) . This interaction stabilizes the complex and facilitates the recruitment of general transcription factors and coactivators, such as the histone acetyltransferases (HATs), CBP, p300, and p300͞CBP-associated factor (PCAF), resulting in the enhancement of transcription (21) (22) (23) (24) (25) (26) . Tax-1 also deregulates the expression of a variety of cellular genes and signaling pathways involved in cell cycle progression, cell growth, DNA repair, and apoptosis. This deregulation is believed to contribute to the initiation of leukemogenesis and maintenance of the malignant phenotype in adult T cell leukemia͞lymphoma (27) (28) (29) .
Tax-2 has Ͼ75% amino acid sequence homology with Tax-1, and although its mechanism of action is assumed to be similar to that of Tax-1, very little is known about the cellular factors interacting with and͞or used by Tax-2 to mediate its biological functions. Moreover, several reports have shown that Tax-1 and Tax-2 have distinct biological properties (30) (31) (32) (33) (34) (35) (36) (37) .
We reported that Tax-2 transactivation of the HTLV-2 LTR is strongly inhibited by the host transcription factor class II transactivator (CIITA). As a consequence, susceptible T and B human cells do not support HTLV-2 replication when expressing CIITA (38) . Similarly, CIITA targets the viral transactivator Tat to inhibit the replication of the HIV-1 virus (39, 40) .
The AIR-1 locus-encoded CIITA is the master regulator of the expression of MHC-II genes (41) (42) (43) that play a key role in the homeostasis of the immune system. MHC-II-encoded molecules present peptides to the antigen receptor of CD4 ϩ T cells, whose activation is required to trigger and modulate both humoral and cellular immune responses (44) . CIITA is a non-DNA-binding transcriptional integrator recruited to MHC-II promoters via multiple interactions with transcription factors bound to DNA, including the regulatory factor X and the nuclear factor Y (NF-Y) complexes (45) (46) (47) (48) (49) (50) .
CIITA interacts with CBP, p300, PCAF, and the cyclin T1 subunit of the positive transcription elongation factor b to enhance MHC-II gene transcription (51) (52) (53) (54) .
The positive transcription elongation factor b is also used by Tat to promote the elongation of HIV-1 viral transcripts (55) , and we have shown that sequestration of cyclin T1 is the major mechanism by which CIITA blocks the transactivating function of Tat (40) . But the molecular basis of the CIITA-mediated inhibition of Tax-2 is still elusive.
To further understand how CIITA affects Tax-2, in the present study we investigated: (i) whether the block of Tax-2 function mediated by CIITA takes place in the cytoplasm or the nucleus; (ii) the minimal region of CIITA retaining the ability to block Tax-2 transactivation; (iii) whether cellular factors used by CIITA to activate MHC-II gene transcription are also used by Tax-2 to transactivate the viral promoter; and (iv) if so, whether CIITA targets one or more of these factors to inhibit Tax-2 function.
We found that the CIITA 1-321 N-terminal region, with an exclusive nuclear distribution, inhibits Tax-2 function and viral replication. We identified CBP and p300 as crucial factors for the Tax-2-directed LTR transactivation. However, they are not involved in CIITA-mediated inhibition of Tax-2. Instead the transcription factor NF-Y was found to inhibit Tax-2 transactivating function.
We present a model to account for the involvement of NF-Y in the negative control of the viral replication exerted by CIITA.
Results
The N-Terminal Region of CIITA Inhibits HTLV-2 Replication in Susceptible B Cells. We previously demonstrated that the N-terminal region of CIITA mediates the inhibition of HTLV-2 LTR transactivation directed by Tax-2 (38) .
To determine whether this inhibition interferes with the life cycle of HTLV-2, we analyzed the capacity of human target cells to support viral replication when expressing different fragments of CIITA. CIITA-defective RJ2.2.5 B cells were stably transfected with chimeric constructs expressing a fusion protein between the GFP and the Flag-tagged full-length CIITA (residues 1-1130) or the deletion mutants 1-321 or 322-1130. Transfectants were sorted on the basis of the green fluorescence and tested for the expression of MHC-II molecules. As shown in Fig. 1 , FACS analysis revealed that GFP did not affect transcriptional activity of CIITA because transfection of the GFPfCIITA1-1130 chimera resulted in cell surface expression of MHC-II-DR. As expected, the C-terminal and N-terminal truncated forms of CIITA failed to activate class II gene expression.
To further characterize RJ2.2.5 transfectants, we analyzed the subcellular distribution of the various GFPfCIITA molecules by confocal microscopy (Fig. 1, confocal microscopy) . In control cells transfected with unmodified GFP a diffuse fluorescent pattern was observed throughout the cells. GFPfCIITA1-1130 displayed dual cytoplasmic and nuclear localization, but was clearly excluded from nucleoli. GFPfCIITA1-321 predominantly accumulated into the nucleus, but not in the nucleoli. In contrast, GFPfCIITA322-1130 showed a strictly cytoplasmic localization. Of note, the observed localization of the various GFPfCIITA chimeras reflects the relative subcellular distribution of the corresponding untagged CIITA molecules (data not shown).
The RJ2.2.5 transfectants were then infected with HTLV-2. The infection efficiency was comparable for all cell lines as assessed by real-time PCR of the tax-2b gene 2 days after infection (Fig. 1,  tax-2b ). Viral replication was extremely different in the various transfectants as indicated by the proviral load values at day 15 after infection. RJ2.2.5 cells supported viral replication when expressing the GFP protein alone or the C-terminal 322-1130 region. In contrast, RJ2.2.5 cells expressing the N-terminal 1-321 fragment or the full-length CIITA did not allow viral replication as demonstrated by their very low proviral load at day 15 (178 and 192 versus 13,680 in the RJ͞GFP cells, respectively). This distinct behavior was not caused by different expression levels of the various GFPfCIITA chimeras because they were equally expressed in the transfectants (Fig. 1, ␣Flag IP, ␣CIITA WB) .
These findings demonstrate that the constitutive expression at physiological levels of the N-terminal 1-321 fragment of CIITA may effectively inhibit viral replication in natural cellular targets of HTLV-2 infection. To identify the minimal sequence of CIITA that inhibits Tax-2 activity we performed a functional mapping of CIITA. A gene reporter assay was carried out in COS cells cotransfected with a HTLV-2 LTR-Luciferase construct, an expression vector for Tax-2, and increasing amounts of the plasmids coding for either CIITA full-length or CIITA deletion mutants. Western blot analyses with anti-Flag antibody showed that all recombinant CIITA proteins were equivalently expressed in the cells ( Fig. 2A) . We assessed the capacity of the various CIITA fragments to inhibit Tax-2-mediated HTLV-2 LTR transactiva- tion. Full-length CIITA significantly reduced the effect of Tax-2 on the HTLV-2 promoter, and the 1-321 CIITA fragment exerted an even more potent inhibition (Fig. 2 A, compare bars 3-5 and 6-8 with bar 2), supporting the results of the infection experiments in RJ2.2.5-transfected cells (Fig. 1) . On the contrary, the C-terminal 322-1130 and 201-1130 fragments of CIITA did not affect Tax-2-mediated transactivation (Fig. 2 A, compare bars 18-20 and 21-23 with bar 2), indicating that the first 200 aa of CIITA are necessary to block Tax-2 function. Interestingly, additional mutants with further deletions of the 1-200 region (fCIITA26-200, fCIITA26-144, and fCIITA64-200) still retained the ability to inhibit Tax-2. Quantitation of luciferase activity showed up to a 20-fold reduction in Tax-2 transactivation at the highest doses of these CIITA fragments (Fig. 2 A, compare bars 11, 14, and 17 with bar 2).
To rule out a toxic effect of the N-terminal CIITA fragments on the transcription machinery during the transient transfection assay, CIITA1-321 or CIITA64-200 were cotransfected in Cos cells with Gal4-VP16 hybrid plasmid and pG5bCAT reporter plasmid (56) . We found that the overexpression of both CIITA1-321 and CIITA64-200 did not inhibit the transcriptional activity of the Gal4-VP16 chimera on the Gal4 responsive promoter of the pG5bCAT construct (data not shown).
We conclude that a short stretch of 80 aa encompassing positions 64-144 of the activation domain of CIITA (Fig. 2B , black boxes) is required for the functional and specific inhibition of Tax-2.
CBP, p300, and PCAF Play a Different Role in the Activation of HTLV-2 LTR, and Their Overexpression Does Not Overcome the CIITA-Mediated Inhibition of Tax-2 Activity. To unveil the biochemical basis of the CIITA-mediated inhibition of Tax-2, we carried out experiments to preliminarily define the host cell factors used by Tax-2 to transactivate the viral promoter.
On the basis of the reported physical and͞or functional interactions shared by Tax-1 and CIITA, we first focused on the role of CBP, p300, and PCAF in the Tax-2-directed LTR transactivation. Increasing amounts of expression vectors for CBP, p300, or PCAF were cotransfected in COS cells with a HTLV-2 LTR-luciferase construct and a Tax-2 expression plasmid. Interestingly, both CBP and p300 significantly increased the transcriptional activity of Tax-2 in a dose-dependent manner (Fig. 3 A and B, bars 3-5 ). In the absence of Tax-2, neither CBP nor p300 had a direct effect on HTLV-2 LTR promoter activation (data not shown). Conversely, no increased luciferase activity was observed when exogenous PCAF was expressed (Fig. 3C , compare bars 3-5 with bar 2), indicating that it did not exert any synergic effect on Tax-2 transactivation, as is the case for HTLV-1 Tax-1 transactivation (refs. 24 and 25 and data not shown).
We conclude that CBP and p300, but not PCAF, cooperate with Tax-2 to promote the transcription from the viral LTR.
If CIITA inhibits HTLV-2 replication by competing with Tax-2 for any of the above HATs, increasing amounts of exogenous CBP, p300, or PCAF should overcome the CIITA-mediated inhibition of Tax-2 function. The overexpression of each of the three factors could not reverse the inhibitory action of CIITA (Fig. 3 , compare bars 7-9 with bar 6), indicating that their squelching is not the major mechanism by which CIITA inhibits Tax-2-directed LTR activation.
The Cellular Transcription Factor NF-Y Inhibits the Tax-2-Dependent
Transactivation of the HTLV-2 LTR Promoter. NF-Y is an ubiquitous transcription factor composed of the NF-YA, NF-YB, and NF-YC subunits that interact in vivo and then bind a consensus DNA sequence present in the Y box of the MHC-II promoters (57, 58) . NF-Y interacts with CIITA, contributing to the formation of the enhanceosome on the promoter-enhancer region of all MHC-II genes, allowing their regulated transcription (45) (46) (47) (48) (49) (50) . It has been shown that NF-YB directly binds to Tax-1 (59) . Because the effect of this interaction on the activation of the viral promoter was not assessed, we verified this aspect by cotransfecting COS cells with the HTLV-2 LTR luciferase vector together with Tax-2 and increasing amounts of the NF-YB expression vector. Notably, we found that NF-YB strongly reduced the Tax-2-mediated, LTR-dependent activation of the luciferase gene (Fig. 4A , compare bars 3-6 with bar 2). It is important to note that 4-fold more NF-YB with respect to CIITA was needed to obtain similar levels of Tax-2 inhibition (Fig.  4A, compare bars 5 and 7) . Interestingly, the inhibition of Tax-2 transactivation by NF-YB was more pronounced in presence of cotransfected CIITA (Fig. 4A , compare bars 8-11 with bar 7). We also tested an additional NF-Y subunit, NF-YA, to verify whether the inhibition of Tax-2 function could reflect the involvement of the assembled NF-Y complex. Again the overexpression of the NF-YA Fig. 3 . CBP and p300 up-regulate Tax-2 activity, but do not counteract the CIITA-mediated inhibition of Tax-2 transactivation. COS cells were cotransfected with pLTRII-Luc (0.2 g), pcTax-2b (bar 2, black), pcTax-2b and increasing amounts of CBP, p300, or fPCAF (A, B, and C, bars 3-5, respectively), pcTax-2b and pcfCIITA (bar 6, gray), and pcTax-2b and pcfCIITA plus increasing amounts of CBP, p300, or fPCAF (A, B, and C, bars 7-9, respectively). Numbers in the grid indicate the amounts (g) of transfected plasmids DNA. Bar 1 (hatched) represents the activity of the pcDNA3 vector. Viral promoter transactivation is expressed as percentage luciferase activity relative to 100% activation by Tax-2 (black bars). The expression of fCIITA, fPCAF, CBP, and p300 was analyzed by anti-Flag, anti-CBP, or anti-p300 immunoblotting (WB) of total cell lysates.
subunit led to a dose-dependent reduction of luciferase activity (Fig. 4B , compare bars 3-6 with bar 2), but the effect was less dramatic compared with NF-YB.
These data show that the NF-Y complex, rather than a single NF-Y subunit, is most likely responsible for the observed inhibitory effect on Tax-2-mediated LTR transactivation. The data also indicate that in the presence of CIITA the inhibitory effect of NF-Y is enhanced.
Discussion
The findings reported here clearly establish that host factors involved in the regulation of MHC-II gene expression, namely CIITA and NF-Y, can negatively regulate HTLV-2 replication by blocking the function of Tax-2 viral transactivator. Moreover, our results demonstrate that Tax-2 differs from Tax-1 in the selective use of HATs for the activation of the viral LTR.
CIITA is a transcription factor with both nuclear and cytoplasmic localization. This dual subcellular distribution is the net result of multiple nuclear import and nuclear export signals (53, (60) (61) (62) (63) (64) (65) . Because Tax-2 activates the viral promoter in the nucleus, it is likely that CIITA inhibits Tax-2 at the nuclear level. Nevertheless, it was recently shown that Tax-2 is a shuttling protein with predominant cytoplasmic accumulation (66) . Thus, the possibility existed that CIITA interferes with Tax-2 in the cytoplasm.
To address this issue we analyzed and correlated the subcellular distribution of several CIITA fragments with their capacity to inhibit HTLV-2 replication. We show that, beside CIITA wild type, the N-terminal 1-321 fragment, which exhibits a restricted nuclear localization, is able to inhibit viral replication. Similarly, we found that the minimal 64-200 fragment of CIITA that still suppresses Tax-2 transactivation of viral LTR, is mostly, if not exclusively, localized in the nucleus (data not shown). In contrast, CIITA322-1130, which displays cytoplasmic localization, does not affect viral replication. These results demonstrate a strict correlation between nuclear localization of CIITA and its capacity to inhibit Tax-2 transactivation. This conclusion is corroborated by our previous finding that BLS2 cells support HTLV-2 replication (38) . These cells express a mutant form of CIITA that retains all of the functional domains of the molecule, but shows an exclusive cytoplasmic localization because of a short in-frame deletion that removes a nuclear localization motif (60) .
The region 1-321 of CIITA is critical not only for the inhibition of HTLV-2 replication but also for the transcription of MHC-II genes. It includes the transcriptional activation domain and, from positions 253-321, the dimerization domain (56) . The N terminus of CIITA also interacts with CBP, p300, PCAF, and subunits of the regulatory factor X and NF-Y complexes (48, (50) (51) (52) (53) . Our mapping experiments define the boundary of the CIITA fragment that is minimally required to suppress Tax-2 transactivation to residues from positions 64-144 (Fig. 2) . This sequence does not overlap with the dimerization domain, implying that CIITA self-association is not a prerequisite for Tax-2 inhibition.
In searching for the intimate molecular basis of Tax-2 inhibition by CIITA we focused on CBP, p300, PCAF, and the NF-Y complex, which are known to interact with both Tax-1 and CIITA. Our studies demonstrate that CBP and p300, but not PCAF, enhance Tax-2-directed LTR transactivation. The fact that PCAF, p300, and CBP all are essential for optimal transactivation by Tax-1 (23) (24) (25) substantiates the existence of important differences between HTLV-2 Tax-2 and HTLV-1 Tax-1. The different requirement for PCAF between the two viral transactivators also implies that Tax-1, but not Tax-2, might influence nuclear PCAF-containing complexes, potentially contributing to the pleiotropic deregulated expression of cellular genes during leukemogenesis. Importantly, Tax-1 mutants, which interact poorly with PCAF, exhibit an impaired transactivation capacity and are defective for transformation (24, 67) . The theme of differential usage of coactivators with HAT activity between Tax-2 and Tax-1 is not new. A recent work by Meertens et al. (68) has shown that whereas Tax-1 can use CBP or p300 for inhibiting p53 Tax-2 uses only CBP. In addition, it has been shown that Tax-1 transforms rat fibroblasts and inhibits p53 function more efficiently than Tax-2 (30, 31). These observations suggest that a selective use of HATs in different transcriptional pathways could be responsible, at least in part, for the higher oncogenic potential of Tax-1 with respect to Tax-2.
We previously demonstrated that CIITA inhibits HIV-1 replication by competing with the Tat transactivator for cyclin T1 (40) . This finding prompted us to determine whether squelching of CBP, p300, or PCAF could account for the observed inhibition of Tax-2 by CIITA. These HATs were attractive candidates in light of the fact that their squelching seems to be a common mechanism by which CIITA mediates gene suppression (69) (70) (71) (72) . We found that direct sequestration of the above cofactors was not the primary mechanism by which CIITA causes suppression of Tax-2 transactivating function.
Interestingly, we found that overexpression of NF-Y significantly inhibited Tax-2-directed HTLV-2 LTR transactivation. A transcriptionally competent NF-Y complex is expressed in COS and RJ2.2.5 cells. Thus, apparently, physiologic levels of NF-Y do not prevent either the Tax-2-mediated LTR-driven gene expression in COS cells or the replication of HTLV-2 virus in RJ2.2.5 cells (Figs. 1 and  2) . On the contrary, CIITA constitutively expressed at physiologic levels in Raji B cells (38) or RJ2.2.5 cells after stable transfection (Fig. 1 and ref. 38 ) dramatically suppresses HTLV-2 productive infection. Cotransfection of NF-Y and suboptimal amounts of CIITA in COS cells resulted in even stronger NF-Y-mediated inhibition of Tax-2 transactivation capacity, which suggests that the NF-Y complex requires CIITA to contribute its inhibitory activity on Tax-2.
On the basis of these findings we propose a molecular model for the CIITA-mediated inhibition of Tax-2 activity via the binding of the CIITA-NF-Y complex to Tax-2 (Fig. 5) . NF-Y expressed in cells at physiologic levels does not efficiently bind Tax-2, which is recruited to the LTR promoter to activate transcription (Fig. 5A) . On the contrary, the overexpression of NF-Y can facilitate the interaction with Tax-2, preventing its recruitment to the viral promoter (Fig. 5B) . When expressed, CIITA interacts with the NF-Y complex; this interaction changes the conformation of NF-Y, increasing its binding affinity for Tax-2. The Tax-2-NF-Y complex is not recruited to the LTR and does not activate transcription (Fig.  5C) . Alternatively, the binding of NF-Y to Tax-2 could still permit its recruitment to the LTR, but not its transcriptional activity. Following our model, the inhibition of Tax-2 by CIITA is not caused by the squelching of a transcriptional positive coactivator, but instead by the recruitment of a cellular factor, NF-Y, with a negative regulatory action on Tax-2.
The results of this study may contribute to therapeutic strategies aimed at counteracting retroviral infections through the control of CIITA expression and͞or the selective use of CIITA fragments.
Methods
Plasmids. pcfCIITA1-1130, pcf1-321, and pcf322-1130 vectors have been described (56) . All Flag-tagged CIITA deletion mutants were generated from pcfCIITA1-1130 by PCR.
pcfCIITA210-1130 was made with primers F201 (5Ј-GGGGG-GAATTCGCCACCATGGACTACAAGGACGACGACG-ACAAGCGCCTGGAGAAAACCGACCAG-3Ј) and 1130R (5Ј-CGATGCTCTAGATCATCTCAGGCTGATCCGTGA-3Ј). PCR product was ligated into EcoRI-XbaI-digested pcDNA3 vector (Invitrogen, Milan, Italy). pcfCIITA26-200 and pcfCI-ITA26-144 were made by using the common primer F26 (5Ј-GGGGGGAATTCGCCACCATGGACTACAAGGACGA-CGACGACAAGGCAGAGTTGGGGCCCCTAGAAGGTGG-CTACC-3Ј) and the 200R (5Ј-GGGGGCTCGAGTCACATCTG-GCCGGAGGCTGGCTCCTGG-3Ј) or 144R (5Ј-GGGGCTC-GAGTCATTTCTGACTTTTCTGCCCAACTTCTG-3Ј) reverse primers, respectively, and ligation into EcoRI-XhoI-cleaved pcDNA3.1(ϩ) vector. Primers used to make pcfCIITA64-200 were: F64 (5Ј-GGGGGGAATTCGCCACCATGGACTACAAGGAC-GACGACGACAAGGCACTCTACTCAGAACCCGACACAG-ACACCATC-3Ј) and the 200R primer. PCR product was ligated into EcoRI-XhoI-cleaved pcDNA3.1(ϩ). All constructs were sequenced. pLTRII-Luc vector containing the HTLV-2 LTR promoter linked to the firefly Luciferase gene, pcTax-2b, pcRmNF-YA, pcmNF-YB, pCMVCBP, and pCMV␤p300 have been described (38, 49, 52, 40) . To obtain the pcfPCAF vector, fPCAF cDNA was excised from the pcxPCAF plasmid (73) by EcoRIKpnI digestion and inserted into EcoRI-KpnI-cleaved pcDNA3.1(Ϫ) vector.
pGFPfCIITA1-1130, pGFPfCIITA1-321, and pGFPfCIITA322-1130 constructs were generated by excision of the corresponding CIITA cDNA from the pcDNA3 vector by digestion with EcoRI, EcoRI-XhoI, and EcoRI-XbaI, respectively. The resulting fragments were ligated into pEGFP-C2 vector (Clontech, Palo Alto, CA) digested with EcoRI, EcoRI-SalI, and EcoRI-XbaI, respectively, to produce GFP chimeras in which the GFP was fused in-frame to the N terminus of Flag-tagged CIITA proteins. The Renilla luciferase reporter vector phRL-CMV was purchased from Promega (Milan, Italy).
Transient Transfections, Luciferase Assay, and Western Blotting. COS cells grown in DMEM supplemented with 10% FCS and 5 mM L-glutamine in 35-mm-diameter plates were transfected with variable amounts of plasmids DNA as indicated for each gene reporter assay and 5 ng of phRL-CMV, using Lipofectamine (Invitrogen). Empty pcDNA3 vector was used as a stuffer DNA in all experiments. Cell extracts were prepared 24 h posttransfection and assayed for luciferase activity by using the Dual Luciferase Reporter Assay System (Promega) according to the manufacturer's instructions. The values of three independent experiments performed in triplicate were calculated as mean luciferase͞renilla ratio Ϯ standard error and expressed as percentages relative to luciferase activity produced by Tax-2 (100%). Cell lysates were analyzed for the expression of recombinant proteins by SDS͞PAGE on 4-12% polyacrylamide gels and Western blotting as described (40) . The following antibodies were used: anti-Flag M2 (Sigma, Milan, Italy) to detect fCIITA proteins and fPCAF; anti-Myc 9E10 (Santa Cruz Biotechnology, Santa Cruz, CA) to detect myc-tagged NF-YA and NF-YB; and anti-CBP (A22) and anti-p300 (N15) (Santa Cruz Biotechnology) to detect CBP and p300, respectively. HRPconjugated anti-mouse Ig or anti-rabbit Ig secondary antibodies (Amersham Pharmacia, Milan, Italy) were used. Blots were developed by chemiluminescence assay (ECL, Amersham Pharmacia).
Stable Transfections, FACS Analysis, and Immunoprecipitations. The MHC-II-negative RJ2.2.5 human B cells (4 ϫ 10 6 ), lacking the expression of the AIR-1 locus product CIITA (41), were transfected by electroporation with 5 g of pGFPfCIITA1-1130, pGFPfCI-ITA1-321, pGFPfCIITA322-1130, or pEGFP-C2 vectors by using the GenePulser II apparatus (Bio-Rad, Richmond, CA) at 320 V͞350 F. Transfected cells were selected and cultivated with 1 mg͞ml neomycin (GIBCO͞BRL, Milan, Italy). GFP ϩ cells were purified by fluorescence-activated cell sorting and analyzed for the cell surface expression of MHC-II molecules with a phycoerythrinconjugated anti-HLA-DR antibody (L243) (Becton Dickinson, Milan, Italy) by cytofluorometry.
The lysate obtained from 70 ϫ 10 6 cells was assayed for the presence of GFPfCIITA recombinant proteins by immunoprecipitation with anti-FlagM2-agarose beads (Sigma) followed by immunoblotting with rabbit sera raised against residues 911-980 (40) or residues 255-321 of CIITA and HRP-conjugated anti-rabbit Ig secondary antibody (Amersham Pharmacia).
GFP Analyses. Stably transfected RJ2.2.5 cells, suspended in PBS, were mounted on microscope slides with coverslips and immediately viewed with a confocal laser microscope (FV500, Olympus, Hamburg, Germany), at room temperature, ϫ60 magnification, 1.40 numerical aperture of the objective lenses, and Fluoview acquisition software. Viral Infection and Assessment of HTLV-2 Proviral Load. Stably transfected RJ2.2.5 cells were cocultured with a double share of HTLV-2 strain Gu-infected BJAB cells and assessed for tax-2b sequences per 10 5 cells by Taqman real-time PCR as described (38 
